VC  Altitude Life Science Ventures

http://www.altitudefunds.com





     Office Locations:

701 5th Avenue, Suite 5400
Seattle, WA 98104

 

Stages:

  • Early


 

Industries:

  • Consumer Products & Services
  • Life Sciences & Healthcare

  •  

    Description:

    The Southern Ute Indian Tribe has sponsored Altitude Life Science Ventures through its wholly owned private equity division, GF Private Equity Group, LLC. Altitude acts as the seed partner and investor in such funds, partnering with experienced management teams with differentiated value-added strategies and compelling track records in their field of expertise. Sectors of interest include: Life Sciences. Altitude's initial investment into a portfolio company is between $1 to $2.5 million with a reserve of significant capital for later rounds. The firm's strategy is to have a balanced portfolio of 15 early stage life companies selected from a portfolio Pool of 35 to 40 companies.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dave Maki Co-Founder
    Steve Johnson Co-Founder

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      07/24/2017


      Effector Therapeutics


      CA


      $38,600,000


      Series C


      04/25/2017


      Sienna Biopharmaceuticals


      CA


      $40,000,000


      Series B


     

    Portfolio companies include:


      Achaogen
        web link


      Arete Therapeutics
        web link


      BlackThorn Therapeutics
        web link


      Cambrios Technologies
        web link


      Constellation Pharmaceuticals
        web link


      Effector Therapeutics
        web link


      Ikaria
        web link


      Kythera
        web link


      Limerick Neurosciences
        web link


      Receptos
        web link


      Sienna Biopharmaceuticals
        web link


      Siluria Technologies
        web link


     

    Recent News: